ATE393785T1 - Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose - Google Patents

Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose

Info

Publication number
ATE393785T1
ATE393785T1 AT02745396T AT02745396T ATE393785T1 AT E393785 T1 ATE393785 T1 AT E393785T1 AT 02745396 T AT02745396 T AT 02745396T AT 02745396 T AT02745396 T AT 02745396T AT E393785 T1 ATE393785 T1 AT E393785T1
Authority
AT
Austria
Prior art keywords
glycopeptides
treatment
multiple sclerosis
diagnosis
preparation
Prior art date
Application number
AT02745396T
Other languages
English (en)
Inventor
Anna Papini
Mario Chelli
Paolo Rovero
Francesco Lolli
Original Assignee
Univ Firenze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE393785(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Firenze filed Critical Univ Firenze
Application granted granted Critical
Publication of ATE393785T1 publication Critical patent/ATE393785T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02745396T 2001-06-22 2002-06-19 Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose ATE393785T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001FI000114A ITFI20010114A1 (it) 2001-06-22 2001-06-22 Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla

Publications (1)

Publication Number Publication Date
ATE393785T1 true ATE393785T1 (de) 2008-05-15

Family

ID=11442221

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745396T ATE393785T1 (de) 2001-06-22 2002-06-19 Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose

Country Status (15)

Country Link
US (1) US7037893B2 (de)
EP (1) EP1406927B1 (de)
AT (1) ATE393785T1 (de)
AU (1) AU2002316989B2 (de)
CA (1) CA2451347C (de)
CZ (1) CZ2004122A3 (de)
DE (1) DE60226324T2 (de)
DK (1) DK1406927T3 (de)
ES (1) ES2305258T3 (de)
HU (1) HUP0400262A3 (de)
IL (2) IL159479A0 (de)
IT (1) ITFI20010114A1 (de)
PL (1) PL207174B1 (de)
PT (1) PT1406927E (de)
WO (1) WO2003000733A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
ITFI20010144A1 (it) * 2001-07-25 2003-01-25 Univ Firenze Colonne per immunoassorbimento per sottrazione di autoanticorpi dal sangue con tecniche di plasmafiltrazione selettiva
WO2004015420A1 (en) * 2002-08-02 2004-02-19 Glycominds Ltd. Method for diagnosing multiple sclerosis
US8216791B2 (en) 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US7572592B2 (en) 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US20080267988A1 (en) * 2007-04-11 2008-10-30 Enteron Limited Partnership Myelin specific IgE unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
JP2010523629A (ja) 2007-04-12 2010-07-15 アピトープ インターナショナル エヌフェー 多発性硬化症のためのバイオマーカー
EP2050761B1 (de) 2007-10-16 2011-06-29 Toscana Biomarkers S.r.l. Galactosylierte Peptide, deren Zubereitung und Verwendung zur Diagnose von Autoimmunerkrankungen
US20100203569A1 (en) 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
ITFI20120164A1 (it) 2012-06-05 2013-12-06 Azienda Ospedaliera Universitaria S Enese 50 Nuovi peptidi glicosilati.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0922057A1 (de) 1996-03-28 1999-06-16 Immulogic Pharmaceutical Corporation Glycoproteinpeptide von myelin-oligodendrozytenund verwendung derselben
WO1999057241A2 (en) * 1998-05-05 1999-11-11 Corixa Corporation Myelin basic protein peptides and uses thereof
CA2341240C (en) * 1998-08-26 2008-04-01 The Regents Of The University Of California Autoantibody inhibitors
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
ITRM20010408A1 (it) * 2001-07-10 2003-01-10 Univ Napoli Federico Ii Mini-anticorpo umano citotossico per cellule tumorali che esprimono il recettore erbb2.

Also Published As

Publication number Publication date
HUP0400262A2 (hu) 2004-08-30
ES2305258T3 (es) 2008-11-01
PL207174B1 (pl) 2010-11-30
US7037893B2 (en) 2006-05-02
WO2003000733A3 (en) 2003-11-13
CZ2004122A3 (cs) 2004-07-14
AU2002316989B2 (en) 2006-10-26
DK1406927T3 (da) 2008-08-18
EP1406927A2 (de) 2004-04-14
ITFI20010114A1 (it) 2002-12-22
CA2451347C (en) 2011-07-19
PL368158A1 (en) 2005-03-21
WO2003000733A2 (en) 2003-01-03
US20040235713A1 (en) 2004-11-25
DE60226324D1 (de) 2008-06-12
IL159479A (en) 2010-12-30
HUP0400262A3 (en) 2008-05-28
DE60226324T2 (de) 2009-07-09
IL159479A0 (en) 2004-06-01
PT1406927E (pt) 2008-07-31
CA2451347A1 (en) 2003-01-03
EP1406927B1 (de) 2008-04-30

Similar Documents

Publication Publication Date Title
ATE477224T1 (de) Verwendung von miniatursierten vorrichtungen zur herstellung von radiomarkierten verbindungen
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
ATE486092T1 (de) Zusammensetzungen und verfahren für die diagnose von tumoren
DE60001564D1 (de) Bicyclische polyamiosaure metallkomplexe, verfahren zu ihrer herstellung und ihre verwendung für medizinische bilderzeugung
HK1050898A1 (en) Intermediate used for manufacturing cascade polymer complexes.
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
CY1110505T1 (el) Ανθρωπινα αντισωματα dr4 και χρησεις αυτων
DE69839782D1 (de) Eine Zusammensetzung, die eine Trägerkomponente und eine gereinigte mykobakterielle Zellwandkomponente enthält, und ihre Verwendung zur Verhinderung, Behandlung und Diagnose von Erkrankungen
ATE393785T1 (de) Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose
FI972703A (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
DE69628336D1 (de) Behandlung und diagnose helicobacter pylori infektionen
NO973459L (no) Vismut-forbindelser
HUP0400697A2 (hu) Elcsendesített anti-CD28 ellenanyagok és használatuk
ATE352311T1 (de) Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
DE60230455D1 (de) Natürliche verbindung für die behandlung von diabetes, deren herstellung und verwendung
WO2004047757A3 (en) Diagnosing and treating hematopoietic cancers
WO2004083241A3 (en) Btc-interacting proteins and use thereof
DE60335610D1 (de) Neoplasma-spezifische antikörper und deren verwendungen
DE60206599D1 (de) Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
FI963170A0 (fi) Menetelmä solujen poikkeavuudesta kärsivien yksilöiden tunnistamiseks i
ATE240352T1 (de) Komplexverbindungen zur diagnose von gefässerkrankungen
ATE390435T1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie
ATE397090T1 (de) Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1406927

Country of ref document: EP